Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | membrane associated proteins in eicosanoid and glutathione metabolism family member | 0.0479 | 0.7176 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0069 | 0.0044 |
Loa Loa (eye worm) | histone methyltransferase | 0.0009 | 0.0069 | 0.0382 |
Schistosoma mansoni | microsomal glutathione s-transferase | 0.011 | 0.159 | 0.217 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0666 | 1 | 1 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0009 | 0.0067 | 0.0372 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0019 | 0.0222 | 0.0286 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0008 | 0.0057 | 0.0025 |
Schistosoma mansoni | cpg binding protein | 0.0032 | 0.0407 | 0.0512 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0069 | 0.0044 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0222 | 0.0253 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0381 | 0.0476 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0057 | 0.0316 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0019 | 0.0222 | 0.0286 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0019 | 0.0222 | 0.0286 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.0225 | 0.029 |
Schistosoma mansoni | loxhd1 | 0.0019 | 0.0222 | 0.0253 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0222 | 0.1228 |
Schistosoma mansoni | hypothetical protein | 0.0425 | 0.6361 | 0.8857 |
Onchocerca volvulus | 0.003 | 0.0381 | 1 | |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0057 | 0.0022 |
Echinococcus multilocularis | cpg binding protein | 0.0032 | 0.0407 | 0.0578 |
Schistosoma mansoni | lipoxygenase | 0.0116 | 0.168 | 0.2296 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0225 | 0.5 |
Schistosoma mansoni | polycystin 1-related | 0.0019 | 0.0222 | 0.0253 |
Brugia malayi | Doublecortin family protein | 0.0019 | 0.0222 | 0.1228 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.0225 | 0.029 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0425 | 0.6361 | 1 |
Echinococcus granulosus | RUN | 0.0019 | 0.0222 | 0.0286 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0008 | 0.0057 | 0.0025 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0063 | 0.0887 | 0.1185 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0008 | 0.0057 | 0.0025 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0666 | 1 | 1 |
Brugia malayi | Smad1 | 0.0008 | 0.0057 | 0.0316 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.0225 | 0.1245 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.0225 | 0.5 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0019 | 0.0222 | 0.0286 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0225 | 0.0257 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.002 | 0.0225 | 0.5 |
Echinococcus multilocularis | Smad4 | 0.0008 | 0.0057 | 0.0025 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.0225 | 0.1245 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0124 | 0.1807 | 1 |
Echinococcus multilocularis | smad | 0.0008 | 0.0057 | 0.0025 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0019 | 0.0222 | 0.0286 |
Brugia malayi | CXXC zinc finger family protein | 0.003 | 0.0381 | 0.2108 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0225 | 0.0257 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0124 | 0.1807 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0032 | 0.0407 | 0.0512 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0057 | 0.0022 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0666 | 1 | 1 |
Schistosoma mansoni | Smad4 | 0.0008 | 0.0057 | 0.0022 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0666 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0222 | 0.1228 |
Echinococcus granulosus | smad | 0.0008 | 0.0057 | 0.0025 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0666 | 1 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0057 | 0.0022 |
Schistosoma mansoni | smad | 0.0008 | 0.0057 | 0.0022 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0222 | 0.1228 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.0225 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0225 | 0.5 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0008 | 0.0057 | 0.0025 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0008 | 0.0057 | 0.0022 |
Echinococcus granulosus | dnaJ subfamily B | 0.0425 | 0.6361 | 1 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0116 | 0.168 | 0.2592 |
Toxoplasma gondii | MAPEG family protein | 0.011 | 0.159 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0008 | 0.0057 | 0.0316 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0225 | 0.0003 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0225 | 1 |
Echinococcus multilocularis | RUN | 0.0019 | 0.0222 | 0.0286 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0057 | 0.0316 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0222 | 0.1228 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0057 | 0.0316 |
Loa Loa (eye worm) | doublecortin family protein | 0.0019 | 0.0222 | 0.1228 |
Echinococcus multilocularis | microsomal glutathione S transferase 3 | 0.011 | 0.159 | 0.2451 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0057 | 0.0785 | 0.4101 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.003 | 0.0381 | 0.2108 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0116 | 0.168 | 0.2592 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.0225 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0124 | 0.1807 | 1 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0057 | 0.0316 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0666 | 1 | 1 |
Echinococcus granulosus | Smad4 | 0.0008 | 0.0057 | 0.0025 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0225 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0225 | 0.0003 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0008 | 0.0057 | 0.0316 |
Schistosoma mansoni | lipoxygenase | 0.0081 | 0.1153 | 0.1558 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0666 | 1 | 1 |
Schistosoma mansoni | rab6-interacting | 0.0019 | 0.0222 | 0.0253 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0019 | 0.0222 | 0.0286 |
Echinococcus granulosus | cpg binding protein | 0.0032 | 0.0407 | 0.0578 |
Loa Loa (eye worm) | Smad1 | 0.0008 | 0.0057 | 0.0316 |
Schistosoma mansoni | rab6-interacting | 0.0019 | 0.0222 | 0.0253 |
Echinococcus granulosus | microsomal glutathione S transferase 3 | 0.011 | 0.159 | 0.2451 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.